<DOC>
	<DOCNO>NCT00376116</DOCNO>
	<brief_summary>In spite success management heart failure , repetitive rehospitalisation high mortality rate remain serious problem . Recent study , especially COMPANION trial , demonstrate cardiac resynchronisation therapy ( CRT ) reduce mortality rehospitalisation heart failure patient . There also evidence telemonitoring heart failure patient potentially reduce mortality morbidity . Recently , Home Monitoring ( HM ) function integrate BIOTRONIK CRT-defibrillators CRT-pacemakers view harness powerful combination CRT close remote monitoring heart failure patient . It possible transmit predefined parameter daily basis implant device web-based platform accessible patient ' physician . Our study evaluate clinical usefulness Biotronik HM function CRT-defibrillators CRT-pacemakers .</brief_summary>
	<brief_title>Home Monitoring Cardiac Resynchronisation Therapy</brief_title>
	<detailed_description>Clinical investigation identify potential predictor mortality rehospitalisation event heart failure patient . A selection predictor primarily compose `` Heart Failure Monitor '' ( HFM ) , implement Biotronik implantable cardioverter defibrillator ( ICDs ) capable deliver cardiac resynchronisation therapy ( CRT ) well CRT-pacemakers . HFM parameter transmit attend physician via Home Monitoring ( HM ) function integrate implanted device . In future , HFM high predictive power may play important role part strategy deliver effective health care heart failure patient indication CRT . Our included patient implant CRT device STRATOS LV-T ( CRT-pacemaker ) , KRONOS LV-T , Lumax HF-T ( CRT-ICD ) . Pre-discharge protocol comprise standard device follow-up , activation HM-function , assessment complication cardiovascular event . At follow-up control 1 , 3 , 6 , 9 , 12 month implantation , standard device follow-up perform complication cardiovascular event assess . At enrollment , 6 12 month postoperative case rehospitalisation , follow parameter document : - Echocardiographic parameter - Quality Life ( Minnesota ) - ECG-parameters , NYHA-classification - Blood pressure , body weight - BNP / NT-pro BNP ( optional ) - 6 minute walk test ( optional ) At 1 , 3 9 month postoperative : - ECG-parameters , NYHA-classification - Blood pressure , body weight - BNP / NT-pro BNP ( optional ) - 6 minute walk test ( optional ) Further documentation : - Change drug treatment - Any cardiovascular event therapeutic intervention - Heart failure relate symptom mean patient diary</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Written patient inform consent Indication CRT ( biventricular bifocal ) Sufficient GSMnetwork coverage patient 's area Stable residence followup ( anticipate ) least 1 documented hospitalisation due heart failure within 12 month enrolment Permanent atrial fibrillation Myocardial infarction instable Angina Pectoris within last 3 month Planned cardiac intervention within next 3 month ( e.g . PTCA , CABG , HTX ) Acute myocarditis Life expectancy 6 month Pregnant breastfeed woman Participation another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Implantable cardioverter-defibrillator</keyword>
	<keyword>Pacemaker</keyword>
	<keyword>Cardiac resynchronisation therapy</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Predictor</keyword>
	<keyword>Mortality</keyword>
	<keyword>Rehospitalization</keyword>
	<keyword>Telemedicine</keyword>
	<keyword>Home Monitoring</keyword>
</DOC>